Scarica l'app Stockscreener
1.95
0.00%
0.00
Opgen Inc Borsa (OPGN) Ultime notizie
OpGen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
OpGen Inc (OPGN) Quarterly 10-Q Report - Quartzy
Biophotonics Global Market Observe Highest Growth of $130.07 - openPR
OpGen secures additional $6 million financing, extends agreement to 2025 By Investing.com - Investing.com Australia
OpGen secures additional $6 million financing, extends agreement to 2025 - Investing.com India
AEI Capital Ltd reports stock transactions in OpGen Inc - Investing.com
AEI Capital Ltd reports stock transactions in OpGen Inc By Investing.com - Investing.com Canada
TG Investment Ltd. Take up 7% Stake in OpGen, Inc. with Shares Traded Across Multiple Exchanges - openPR
OpGen (NASDAQ:OPGN) Research Coverage Started at StockNews.com - Defense World
Optical Genome Mapping Market Size and Emerging Trends - Economica
Sepsis Diagnostics Market Analysis: Key Trends, Growth Drivers and Key Companies - Newstrail
Optical Genome Mapping Market 2024 Key Insights - Economica
Antimicrobial Resistance Surveillance Market Worth $7.7 Billion By 2028 As Revealed In New Report - WhaTech
Clinical Microbiology Global Market Insights Discussed Regarding Report 2024Statistics, Analysis - WhaTech
Optical Genome Mapping Market Future Path Key Industry Insights to 2031 – news - Global Reverse Circulation ...
Point of Care Molecular Diagnostics Market Trends and Strategy: $3.4 Billion Industry by 2028 As Revealed I... - WhaTech
Blood Culture Tests Market 2024: Pioneering Innovations in Diagnostic Healthcare As Discussed In New Market... - WhaTech Technology and Markets News
Antimicrobial Resistance Surveillance Market Size Report 2032 By Top Research Firm - WhaTech
Biophotonics Market Insights Discussed Regarding Size, Share, Trends Outlook And Global Forecast 2024 To 2033 - WhaTech
OpGen’s Strategic Moves Amid Nasdaq Delisting and New Financing - TipRanks
OPGN Stock Earnings: OpGen Reported Results for Q2 2024 - InvestorPlace
OpGen discloses restatement of Q1 2024 financials due to error - Investing.com India
OpGen discloses restatement of Q1 2024 financials due to error By Investing.com - Investing.com UK
OpGen (OPGN) Free Cash Flow : $-10.91 Mil (TTM As of Mar. 2024) - GuruFocus.com
OpGen Inc appoints five new directors to its board - Investing.com India
OpGen Bolsters Board with Five New Industry Experts - TipRanks
OpGen (NASDAQ:OPGN) Coverage Initiated at StockNews.com - Defense World
Upcoming Opportunities in High-Resolution Genomic Mapping - openPR
OpGen (NASDAQ:OPGN) Now Covered by StockNews.com - Defense World
OpGen announces leadership change and equity transaction - Investing.com India
OpGen Leadership Changes: CEO Resigns, New Chairman Appointed - TipRanks
OpGen announces leadership change and equity transaction By Investing.com - Investing.com UK
StockNews.com Begins Coverage on OpGen (NASDAQ:OPGN) - Defense World
Antimicrobial Resistance Surveillance Market Size to Hit - GlobeNewswire
Antimicrobial Resistance Surveillance Market Size to Hit US$ 9.50 Billion by 2032, Rising Prevalence of Drug-Resistant Infections Drives Growth | Research by SNS Insider - India Shorts
OpGen (NASDAQ:OPGN) Stock Quotes, Forecast and News Summary - Benzinga
OpGen (NASDAQ:OPGN) Receives New Coverage from Analysts at StockNews.com - Defense World
[Key Companies] Optical Genome Mapping Instruments Market | OpGen, Inc, Bionano Genomics - Economica
Optical Genome Mapping Market to reach a valuation of USD - GlobeNewswire
Optical Genome Mapping Market to reach a valuation of USD 1.3 billion by 2034, at a CAGR of 23.5% | Future Market Insights, Inc. - Yahoo Finance
OPGN Stock Earnings: OpGen Reported Results for Q1 2024 - MSN
OpGen stock jumps after David Lazar invests $3M, takes over as CEO - MSN
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K - Quantisnow
OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. ... - Quantisnow
OpGen (NASDAQ:OPGN) Shares Pass Below 50 Day Moving Average of $4.12 - Defense World
Global Healthcare & Medical Tourism News - Medical Tourism Magazine
OpGen to Provide Business Update and Financial Results for the Third Quarter 2022 on November 10th at 4:30 p.m. ... - OpGen, Inc.
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update - br.ADVFN.com
OpGen Announces $3.38 Million Registered Direct Offering - br.ADVFN.com
OpGen (NASDAQ:OPGN) Stock Price Passes Below 50 Day Moving Average of $4.76 - Defense World
OPGN Stock Earnings: OpGen Meets Revenue for Q4 2023 - MSN
OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Proposals Passed - br.ADVFN.com
1.38%
0.43%
Capitalizzazione:
|
Volume (24 ore):